Suboxone Sales Data
| Rank 39 | Current sales rank, all U.S. Pharmaceuticals. |
Last updated: February 2014 (updated quarterly).
The following data shows Suboxone U.S. retail sales in Q4 2013 compared to previous quarters.
| Date Range | Sales Rank | Sales ($000) | Units (000) | ||
|---|---|---|---|---|---|
| Q4 2013 | 39 ( 3) |
$321,892 | -2.11% | 1,657 | -3.16% |
| Q3 2013 | 36 ( 1) |
$328,832 | -2.46% | 1,711 | -4.15% |
| Q2 2013 | 37 (9) |
$337,109 | -18.95% | 1,785 | -13.60% |
| Q1 2013 | 28 (1) |
$415,929 | -0.32% | 2,066 | 0.58% |
| Q4 2012 | 27 (1) |
$417,264 | 6.18% | 2,054 | 2.65% |
| Q3 2012 | 28 (14) |
$392,977 | 14.63% | 2,001 | 4.93% |
| Q2 2012 | 42 (2) |
$342,816 | 1.17% | 1,907 | 1.98% |
| Q1 2012 | 44 | $338,840 | 2.14% | 1,870 | 2.58% |
| Q4 2011 | 44 (1) |
$331,741 | 6.35% | 1,823 | 1.73% |
| Q3 2011 | 43 (4) |
$311,941 | 6.42% | 1,792 | 3.23% |
| Q2 2011 | 47 (6) |
$293,115 | 3.08% | 1,736 | 4.08% |
| Q1 2011 | 53 | $284,350 | n/a | 1,668 | n/a |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
